{"data":{"type":"investor_profile","id":478098,"entity_id":"wefunder:investor_profile:478098","attributes":{"entity_ids":{"investor_profile":"wefunder:investor_profile:478098","subject":"wefunder:user:913421"},"name":"Gregory Steiner","canonical_url":"https://wefunder.com/gregorysteiner2","description":"See Gregory Steiner's recent startup investments, sectors of interest, and updates. Follow their activity and discover companies on Wefunder.","bio":"CEO of SteinerBio and OsNovum","profile_image_url":"http://uploads.wefunder.com/uploads/user/avatar/913421/medium_large_cropped_Dr._Steiner.jpg","follower_count":25,"interests":[],"recent_investments":[{"company_id":63072,"company_entity_id":"wefunder:company:63072","company_name":"OsNovum","company_url":"https://wefunder.com/osnovum","applied_at":"2024-06-17T21:18:05Z"}],"recent_posts":[{"id":145483,"entity_id":"wefunder:feed_item:145483","type":"FeedItem::Update","title":"OsNovum Status","preview":"Hello OsNovum Owners,Our team at OsNovum has been quite busy. \u0026nbsp;We have closed funding, raising a total sum of $225,000. Wefunder will collect a small percentage of the total fee for helping us with the crowd funding project but ultimately, OsNovum will receive over $200,000 with the primary purpose of completing the FDA application and product clearance to market in the US. All proposed tests are now underway. Six tests are currently at NAMSA and are due to complete in approximately 2 mo...","published_at":"2021-06-02T16:25:29Z","canonical_url":"https://wefunder.com/feed/145483"},{"id":141412,"entity_id":"wefunder:feed_item:141412","type":"FeedItem::Update","title":"New Methods of Diagnosing Who Will Suffer a Bone Fracture","preview":"The current method of screening for risk of a fragility fracture is a dual-energy X-ray absorptiometry scan commonly referred to as DXA. The scan measures bone mineral density (BMD) and provides the patient and practitioner with a reading (T-score) that is used to determine if the patient has bone loss requiring treatment to prevent fracture:A patient is said to have normal bone when the T-score is higher than -1.0 SD.A patient is diagnosed with osteopenia when the T-score is between -1.0 and...","published_at":"2021-01-30T21:25:46Z","canonical_url":"https://wefunder.com/feed/141412"},{"id":141390,"entity_id":"wefunder:feed_item:141390","type":"FeedItem::Update","title":"Research findings: OsNovum reduces inflammation and stimulates bone growth.","preview":"The results are in and we are very proud to share the results of our first major FDA study for OsNovum. Our study for FDA clearance started in 2016 and we have now received the results. The study is a highly controlled study that requires registration with the FDA and the USDA. Over a thousand pages of documents have been complied to comply with FDA requirements. These studies are required to hire an independent outside quality control personnel to monitor all phases of the study. The FDA rev...","published_at":"2021-01-25T21:24:02Z","canonical_url":"https://wefunder.com/feed/141390"},{"id":141360,"entity_id":"wefunder:feed_item:141360","type":"FeedItem::Update","title":"Bone Repair vs Bone Regeneration","preview":"Most bone researchers study with bone repair. This is because orthopedic surgeons spend the majority of their time fixing damaged bones. The process of a long bone repair has very little to do with the process of bone regeneration. Our bones cannot fully heal themselves. Yes, broken bones can be made functional, but seldom is a repaired bone as good as new.At OsNovum we are only interested in bone regeneration. For regeneration to occur, the bone must be as good as new, or it is not regenerat...","published_at":"2021-01-23T20:48:10Z","canonical_url":"https://wefunder.com/feed/141360"},{"id":141221,"entity_id":"wefunder:feed_item:141221","type":"FeedItem::Update","title":"Factors Affecting Osteoporosis","preview":"Osteoporosis is like many of our chronic diseases of aging. Osteoporosis is associated with systemic inflammation. We know that an inflammatory environment stimulates osteoclasts to proliferate and remove bone and it stops osteoblasts from forming bone. However, this inflammation is not what we recognize as inflammation. There is no redness or swelling. The inflammation is characterized by circulating inflammatory molecules or inflammatory bacteria. You cannot look at the tissue to see the in...","published_at":"2021-01-19T21:28:01Z","canonical_url":"https://wefunder.com/feed/141221"},{"id":141121,"entity_id":"wefunder:feed_item:141121","type":"FeedItem::Update","title":"OsNovum nearing 150K in funding.","preview":"OsNovum has reached a milestone that will allow us to complete our submission and clearance with the FDA. This was our primary goal in selling shares of OsNovum and we thank all of those who have invested. We have been live on Wefunder for approximately 1 month and have 3 weeks left to raise additional capital. Our plan is to complete our submission and clearance for OsNovum and when we have acquired clearance, the value of your OsNovum shares will be significantly enhanced and our ability to...","published_at":"2021-01-16T21:03:11Z","canonical_url":"https://wefunder.com/feed/141121"},{"id":140658,"entity_id":"wefunder:feed_item:140658","type":"FeedItem::Update","title":"Osteoporosis drugs- effectiveness and side effects","preview":"OsNovum was developed to fill a need not realized by the available osteoporosis drugs. The use antiresorptive (bone removal) osteoporosis medications have declined in use as osteoporosis diagnosis has increased. Questionable effectiveness including serious side effects have pushed many patients away from using these medications irrespective of their serious osteoporotic condition. The main class of antiresorptive osteoporosis drugs is the bisphosphonates. These drugs gained notoriety due to t...","published_at":"2021-01-01T23:03:17Z","canonical_url":"https://wefunder.com/feed/140658"},{"id":140153,"entity_id":"wefunder:feed_item:140153","type":"FeedItem::Update","title":"OsNovum testing progress","preview":"We have been making good progress with our testing for FDA submission. We have just received our histopathology report that looks at inflammation produced by the bone graft at different time points. We compared a control (no graft) to a cadaver bone graft and our graft. The findings are in, but the final statistical analysis is not yet complete, but it looks very good for our product. For the second component of our FDA submission, we are contracting with a major biomedical testing company to...","published_at":"2020-12-24T20:20:49Z","canonical_url":"https://wefunder.com/feed/140153"},{"id":139905,"entity_id":"wefunder:feed_item:139905","type":"FeedItem::Update","preview":"OsNovum Owners update: FDA testingThe FDA does not have rules to follow when submitting a material for clearance to market a product. The FDA only has guidelines and it is up to the company to convince the FDA that the tests performed on the product are sufficient to determine that product is safe and effective. In addition to no rules, what is accepted will be determined by the attitude of the office who reviews the submission. When you submit to the FDA the officer will reply with a list of...","published_at":"2020-12-15T00:10:30Z","canonical_url":"https://wefunder.com/feed/139905"},{"id":139697,"entity_id":"wefunder:feed_item:139697","type":"FeedItem::Update","preview":"I have just responded to an inquiry about projected revenue for OsNovum. I used percutaneous vertebroplasty as an example of how common collapsed vertebra are and the cost associated with treatment. I used these figures to give an idea of how OsNovum can be used for this problem and how much revenue can be generated. Percutaneous vertebroplasty injects plastic into the vertebrae to support it and stabilize it. The plastic never goes away. The type of material used in percutaneous vertebroplas...","published_at":"2020-12-08T22:38:22Z","canonical_url":"https://wefunder.com/feed/139697"}],"provenance":{"source":"wefunder_public_investor_profile","as_of":"2026-06-04T16:45:08Z","claims":{"follower_count":{"source":"InvestorProfile#followers_count","last_verified_at":"2023-09-25T20:32:48Z","as_of":"2026-06-04T16:45:08Z","confidence":"high"}}},"updated_at":"2023-09-25T20:32:48Z"}}}